In anesthetized rats, NTS microinjection of losartan reversed the CSAR-induced blunted baroreflex control of RSNA (Gain max from 1.65 to 2.22 %/mmHg, P<0.01).
Blockade of AT1 receptors in the NTS improves blunted baroreflex during cardiac sympathetic afferent reflex activation in rats, highlighting a central mechanism for autonomic regulation.
Absolute Event Rate: 2.22% vs 1.65%
p-value: p=< 0.01
The cardiac "sympathetic afferent" reflex (CSAR) has been reported to increase sympathetic outflow and depress baroreflex function via a central angiotensin II (ANG II) mechanism. In the present study, we examined the role of ANG II type 1 (AT(1)) receptors in the nucleus tractus solitarii (NTS) in mediating the interaction between the CSAR and the baroreflex in anesthetized rats. We examined the effects of bilateral microinjection of AT(1) receptor antagonist losartan (100 pmol) into the NTS on baroreflex control of renal sympathetic nerve activity (RSNA) before and after CSAR activation by epicardial application of capsaicin (0.4 microg). Using single-unit extracellular recording, we further examined the effects of CSAR activation on the barosensitivity of barosensitive NTS neurons and the effects of intravenous losartan (2 mg/kg) on CSAR-induced changes in activity of NTS barosensitive neurons. Bilateral NTS microinjection of losartan significantly attenuated the increases in arterial pressure, heart rate, and RSNA evoked by capsaicin but also markedly (P < 0.01) reversed the CSAR-induced blunted baroreflex control of RSNA (Gain(max) from 1.65 +/- 0.10 to 2.22 +/- 0.11%/mmHg). In 17 of 24 (70.8%) NTS barosensitive neurons, CSAR activation significantly (P < 0.01) inhibited the baseline neuronal activity and attenuated the neuronal barosensitivity. In 11 NTS barosensitive neurons, intravenous losartan effectively (P < 0.01) normalized the decreased neuronal barosensitivity induced by CSAR activation. In conclusion, blockade of NTS AT(1) receptors improved the blunted baroreflex during CSAR activation, suggesting that the NTS plays an important role in processing the interaction between the baroreflex and the CSAR via an AT(1) receptor-dependent mechanism.
Wang et al. (Fri,) conducted a other in Anesthetized rats. Losartan vs. Baseline / CSAR activation without losartan was evaluated on Baroreflex control of renal sympathetic nerve activity (Gain max) (p=< 0.01). In anesthetized rats, NTS microinjection of losartan reversed the CSAR-induced blunted baroreflex control of RSNA (Gain max from 1.65 to 2.22 %/mmHg, P<0.01).